CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth

Shasha Yin1, Liu Liu1, Lauren E Ball2

  • 1Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

Cell Reports
|March 30, 2023
PubMed

Insights

Protein arginine methyltransferase 1 (PRMT1) regulates the GATOR2 complex and mTORC1 signaling. Targeting the CDK5-PRMT1-WDR24 pathway inhibits hepatocellular carcinoma cell growth and tumor progression.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and metabolism.
  • The GATOR2 complex links amino acid availability to mTORC1.
  • Dysregulated mTORC1 signaling contributes to cancer development.

Purpose of the Study:

  • To identify novel regulators of the GATOR2 complex and mTORC1 signaling.
  • To elucidate the molecular mechanism linking amino acid sensing to mTORC1 activation.
  • To investigate the therapeutic potential of targeting this pathway in hepatocellular carcinoma (HCC).

Main Methods:

  • Protein interaction studies
  • Phosphorylation and methylation assays
  • Cell proliferation assays
  • Xenograft tumor models
  • Analysis of patient HCC samples

Main Results:

  • Protein arginine methyltransferase 1 (PRMT1) was identified as a key regulator of GATOR2.
  • Cyclin-dependent kinase 5 (CDK5) phosphorylates PRMT1, promoting its translocation and subsequent methylation of WDR24.
  • This CDK5-PRMT1-WDR24 axis activates mTORC1 signaling.
  • Disrupting this axis suppressed HCC cell proliferation and tumor growth.
  • High PRMT1 expression correlated with elevated mTORC1 signaling in HCC patients.

Conclusions:

  • A novel regulatory mechanism involving phosphorylation and arginine methylation controls mTORC1 activation.
  • The CDK5-PRMT1-WDR24 pathway is crucial for HCC cell growth.
  • Targeting this pathway offers a potential therapeutic strategy for hepatocellular carcinoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K